Selling shares in a privately held company is one of the most legally complex transactions a business owner can undertake. Unlike an asset sale, a share sale transfers ownership, rights, and in many cases liabilities. The combination of close personal relationships, limited public information about the company's true financial position, and high financial stakes means disputes can escalate quickly and expensively in both Ontario and BC.
Share sale disputes are among the most frequently litigated commercial matters in both provinces. They involve breach of contract claims, misrepresentation, oppression remedy applications, and in serious cases fraud. Most of them are avoidable. This article identifies the five mistakes that most consistently lead to litigation in private company share transactions and what to do instead. For context on how shareholder disputes unfold more broadly, see our guide to shareholder disputes in Ontario and BC.
The five mistakes below are not hypothetical risks. They are the recurring patterns that produce the shareholder litigation that Ontario and BC courts see most frequently. Avoiding them requires legal involvement before and during the transaction, not after a dispute has emerged.
Selling shares without a defensible independent valuation
Private company shares have no market-determined price. When buyer and seller agree on a price without an independent valuation, they are agreeing to a number without a defensible foundation. If the deal closes and either party later concludes they were wrong about the value, litigation follows.
Disputes over share valuation are among the most common triggers for shareholder litigation in Ontario and BC. They arise as breach of contract claims where the purchase price was based on financial information that proved inaccurate, as oppression remedy applications where minority shareholders argue their shares were undervalued, and as post-closing adjustment disputes where the parties defined value differently in the agreement.
Courts in Ontario and BC give significant deference to valuation evidence from qualified business valuators. A party who enters litigation without a credible independent valuation is at a significant disadvantage. The oppression remedy can be used to challenge a share buyout where the valuation methodology was unfair or the minority shareholder was excluded from the process.
Misrepresenting or failing to disclose financial information
Misrepresentation is one of the most common bases for litigation in share transactions. A buyer who discovers after closing that the financial information provided was inaccurate, incomplete, or deliberately misleading has claims for fraudulent misrepresentation, negligent misrepresentation, and breach of the representations and warranties in the share purchase agreement.
Common misrepresentation issues include financial statements that do not reflect true revenue or liabilities, hidden debts or undisclosed litigation, inflated projections presented as reliable forecasts, and mischaracterized customer or supplier relationships. Each of these can ground a post-closing claim that the buyer would not have entered the transaction, or would not have paid the price agreed, had the true position been disclosed.
Remedies for misrepresentation in share sales include rescission of the purchase, damages for the full loss suffered, and in cases of fraudulent conduct, punitive damages. Directors and officers who personally made or authorized misrepresentations can face personal liability independently of the corporate claim. Under both Ontario's Business Corporations Act and BC's Business Corporations Act, directors who participate in fraudulent misrepresentation are not shielded by the corporate structure.
Sharing confidential business information without a signed confidentiality agreement
A share sale requires extensive disclosure of sensitive business information: financial statements, customer lists, supplier arrangements, pricing structures, trade secrets, intellectual property, and business plans. This information is shared during the due diligence process, which often occurs before any commitment to proceed with the transaction has been made.
Sharing this information without a signed confidentiality and non-use agreement creates serious risk. A prospective buyer who receives detailed financial and operational information and then does not proceed with the transaction retains knowledge that can be used to compete with or harm the target business. Where that information is used to establish a competing business, solicit the seller's customers, or otherwise exploit the seller's position, claims for breach of confidence and injunctive relief follow.
Both Ontario and BC courts have broad jurisdiction to grant injunctions and award damages for breach of confidence. An Anton Piller order can be sought urgently to preserve evidence where there is a risk that confidential information is being used or disclosed. The confidentiality agreement should specify what information is covered, how it can be used, what happens to it if the transaction does not proceed, and what remedies are available for breach.
Overlooking the rights of minority shareholders
Minority shareholders in Ontario and BC corporations are heavily protected by statute. A share transaction that undervalues their interests, excludes them from a process they are entitled to participate in, or is conducted without proper notice can ground an oppression remedy application that derails or reverses the transaction entirely.
The oppression remedy is available under section 248 of Ontario's Business Corporations Act, section 241 of the Canada Business Corporations Act, and section 227 of BC's Business Corporations Act. The Supreme Court of Canada confirmed the modern oppression test in BCE Inc. v. 1976 Debentureholders, 2008 SCC 69: the court asks whether the reasonable expectations of the complainant as a shareholder were violated by conduct that is oppressive, unfairly prejudicial, or unfairly disregards their interests. Remedies can be sweeping: court-ordered buyouts, reversal of the transaction, damages, and removal of directors.
In closely held corporations, minority shareholders often have reasonable expectations beyond what the corporate statutes explicitly provide: expectations about ongoing involvement in management, fair treatment in exit transactions, and access to financial information. Failing to consider those expectations, even where no explicit legal right has been violated, can produce a successful oppression claim.
Finalizing the transaction without proper legal documentation
Share transactions involve a stack of complex documents: share purchase agreements, shareholders' agreements, unanimous shareholder agreements, corporate resolutions, due diligence documentation, and non-solicitation and confidentiality provisions. Poorly drafted or incomplete documentation is one of the most consistent sources of post-closing disputes in both Ontario and BC.
Common documentation problems include undefined or ambiguous valuation methods in buy-sell provisions, contradictory terms between the share purchase agreement and the existing shareholders' agreement, missing signatures or required corporate approvals, incorrect waivers or releases that fail to cover related claims, ambiguous representations and warranties with inadequate indemnification provisions, and failure to comply with the Business Corporations Act or Canada Business Corporations Act requirements for the transaction.
When documentation problems emerge after closing, the parties typically end up in shareholder disputes, breach of contract litigation, or applications for injunctions and emergency court orders. The cost of resolving these disputes consistently exceeds the cost of proper legal documentation at the outset. This is the mistake that legal advice before the transaction most directly prevents.
Involved in a private company share transaction in Ontario or BC that has produced a dispute or is heading toward one?
Share sale disputes move quickly once they start. A party who acted first in asserting their position, preserving evidence, or seeking urgent court relief is in a structurally better position than one who responds. Get legal advice on your position before the other side has already acted.
Call: 1-800-771-7882 Get Advice on Your Share Sale DisputeHow these mistakes translate into litigation
Each of the five mistakes above has a direct path to litigation. No valuation leads to post-closing disputes about whether the price was fair. Misrepresentation leads to rescission claims and damages. Missing confidentiality agreements lead to breach of confidence claims and injunction applications. Overlooked minority rights lead to oppression remedy applications. Poor documentation leads to breach of contract claims and disputes about what was actually agreed.
The litigation that results is expensive, disruptive, and often disproportionate to the amount in dispute. A share sale where the parties end up in court over a $500,000 difference in valuation may generate $200,000 in legal costs on each side before the matter resolves. The mistake that produced the dispute typically cost a fraction of that to avoid.
Planning a private company share sale in Ontario or BC and want to structure it to avoid litigation?
The five mistakes that produce most share sale disputes are avoidable with legal involvement before the transaction closes. Get advice on your specific situation now.
Structure Your Transaction to Avoid Disputes Or call us: 1-800-771-7882Practical takeaways
Frequently asked questions
What are the most common reasons share sale disputes end up in court in Ontario and BC?
The most common triggers are disputes over valuation, misrepresentation or non-disclosure of financial information, breach of confidentiality, oppression of minority shareholders, and poorly drafted transaction documents. Each of these can produce breach of contract claims, oppression remedy applications, or misrepresentation claims that are expensive to resolve and could have been avoided with proper pre-transaction legal advice.
What is the oppression remedy and how does it apply to share sales?
The oppression remedy allows minority shareholders to seek court relief where a share transaction is unfair, prejudicial, or conducted in a way that unfairly disregards their interests. It is available under section 248 of Ontario's Business Corporations Act, section 241 of the Canada Business Corporations Act, and section 227 of BC's Business Corporations Act. The Supreme Court of Canada confirmed the modern test in BCE Inc. v. 1976 Debentureholders, 2008 SCC 69. Remedies can include court-ordered buyouts, reversal of the transaction, and damages.
Why is a share valuation important before selling private company shares?
Private company shares have no market price. Without an independent valuation, the parties have no defensible foundation for the agreed price and are exposed to post-closing disputes about fair market value, goodwill, and asset and liability treatment. Courts in Ontario and BC give significant deference to qualified business valuator evidence in shareholder litigation. A valuation obtained before negotiations begins protects both parties.
What happens if a seller misrepresents financial information in a share sale?
The buyer can bring claims for fraudulent misrepresentation, negligent misrepresentation, or breach of representations and warranties. Remedies include rescission, damages, and in cases of fraudulent conduct, punitive damages. Directors and officers who personally made or authorized misrepresentations can face personal liability under both Ontario and BC corporate statutes independently of the corporate claim.
Do minority shareholders have rights when a share sale is being negotiated?
Yes. Minority shareholders are protected by the oppression remedy in both Ontario and BC. A share transaction that undervalues their interests, excludes them from a process they are entitled to participate in, or is conducted without proper notice can ground an oppression application. In closely held corporations, courts consider reasonable expectations beyond what is explicitly stated in the corporate statutes, including expectations about fair treatment in exit transactions.